Left ventricular mass assessment by CMR; how to define the optimal index.
作者信息
van der Wall E E, Siebelink H M, Bax J J
出版信息
Int J Cardiovasc Imaging. 2010 Apr;26(4):469-72. doi: 10.1007/s10554-010-9602-7. Epub 2010 Mar 6.
Abstract
摘要
相似文献
1
Left ventricular mass assessment by CMR; how to define the optimal index.
Int J Cardiovasc Imaging. 2010 Apr;26(4):469-72. doi: 10.1007/s10554-010-9602-7. Epub 2010 Mar 6.
2
Body size adjustments for left ventricular mass by cardiovascular magnetic resonance and their impact on left ventricular hypertrophy classification.
Int J Cardiovasc Imaging. 2010 Apr;26(4):459-68. doi: 10.1007/s10554-010-9584-5. Epub 2010 Jan 27.
3
Left ventricular trabeculation assessment with cardiac magnetic resonance.
J Cardiovasc Med (Hagerstown). 2010 Jul;11(7):477. doi: 10.2459/JCM.0b013e32833833bc.
4
Left ventricle trabeculae.
J Cardiovasc Med (Hagerstown). 2010 Jul;11(7):552. doi: 10.2459/jcm.0b013e3283357590.
5
Improving cardiovascular risk stratification in essential hypertensive patients by indexing left ventricular mass to height(2.7).
J Hypertens. 2009 Dec;27(12):2465-71. doi: 10.1097/HJH.0b013e32833105a6.
6
Comparative assessment of 2-dimensional echocardiography vs cardiac magnetic resonance imaging in measuring left ventricular mass in patients with and without end-stage renal disease.
Can J Cardiol. 2013 Mar;29(3):384-90. doi: 10.1016/j.cjca.2012.07.013. Epub 2012 Oct 25.
7
Discrepancies in Left Ventricular Mass Calculation Based on Echocardiography and Cardiovascular Magnetic Resonance Measurements in Patients with Left Ventricular Hypertrophy.
J Am Soc Echocardiogr. 2015 Oct;28(10):1194-1203, e2. doi: 10.1016/j.echo.2015.06.009. Epub 2015 Jul 17.
8
Left ventricular trabeculae: quantification in different cardiac diseases and impact on left ventricular morphological and functional parameters assessed with cardiac magnetic resonance.
J Cardiovasc Med (Hagerstown). 2009 Nov;10(11):827-33. doi: 10.2459/JCM.0b013e32832e1c60.
9
Left ventricular mass by echocardiographic measures in children and adolescents.
Cardiol Young. 2013 Oct;23(5):727-37. doi: 10.1017/S1047951112001862. Epub 2012 Nov 20.
10
Geometric assessment of asymmetric septal hypertrophic cardiomyopathy by CMR.
JACC Cardiovasc Imaging. 2012 Jul;5(7):702-11. doi: 10.1016/j.jcmg.2012.03.011.
引用本文的文献
1
Clinical and imaging characteristics of cardiac magnetic resonance presenting with myocardial infarction with non-obstructive coronary arteries in China.
J Cardiothorac Surg. 2022 Dec 22;17(1):332. doi: 10.1186/s13019-022-02072-6.
本文引用的文献
1
The role of cardiac magnetic resonance imaging in differentiating the underlying causes of left ventricular hypertrophy.
Neth Heart J. 2010 Mar;18(3):135-43. doi: 10.1007/BF03091752.
2
Body size adjustments for left ventricular mass by cardiovascular magnetic resonance and their impact on left ventricular hypertrophy classification.
Int J Cardiovasc Imaging. 2010 Apr;26(4):459-68. doi: 10.1007/s10554-010-9584-5. Epub 2010 Jan 27.
3
The importance of cardiac MRI as a diagnostic tool in viral myocarditis-induced cardiomyopathy.
Neth Heart J. 2009 Dec;17(12):481-6. doi: 10.1007/BF03086308.
4
Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: Dutch cardiologists and the care of mutation carriers.
Neth Heart J. 2009 Dec;17(12):464-9. doi: 10.1007/BF03086305.
5
Hypertrophic cardiomyopathy family with double-heterozygous mutations; does disease severity suggest doubleheterozygosity?
Neth Heart J. 2009 Dec;17(12):458-63. doi: 10.1007/BF03086304.
6
Cardiomyopathies: a revolution in molecular medicine and cardiac imaging.
Neth Heart J. 2009 Dec;17(12):456-7. doi: 10.1007/BF03086303.
7
Regression of left ventricular mass by antihypertensive treatment: a meta-analysis of randomized comparative studies.
Hypertension. 2009 Nov;54(5):1084-91. doi: 10.1161/HYPERTENSIONAHA.109.136655. Epub 2009 Sep 21.
8
Left ventricular hypertrophy and renin-angiotensin system blockade.
Curr Hypertens Rep. 2009 Jun;11(3):167-72. doi: 10.1007/s11906-009-0030-9.
9
Prognostic significance of increased left ventricular mass index to mortality and sudden death in patients with stable coronary heart disease (from the Heart and Soul Study).
Am J Cardiol. 2008 Nov 1;102(9):1131-5. doi: 10.1016/j.amjcard.2008.06.036. Epub 2008 Aug 27.
10
Left ventricular volumes and mass in marathon runners and their association with cardiovascular risk factors.
Int J Cardiovasc Imaging. 2009 Jan;25(1):71-9. doi: 10.1007/s10554-008-9337-x. Epub 2008 Aug 3.
Zotero 插件